TSCA Hot Topics: Inventory Notification and Strategies for Complying, and Update on Section 5

Price: $0 OnDemand

Meet The Speakers

Lynn L. Bergeson
Managing Partner, Bergeson & Campbell, P.C.
Charles M. Auer
Senior Regulatory and Policy Advisor, Bergeson & Campbell, P.C.
Richard E. Engler, Ph.D.
Senior Chemist, Bergeson & Campbell, P.C.
Jeffery Morris
Ph.D., Director of the Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency
Lawrence E. Culleen
Partner, Arnold & Porter Kaye Scholer
Pat Rizzuto
Reporter, Bloomberg BNA


This is a complimentary program sponsored by Bergeson & Campbell.

Bergeson & Campbell

With the recent release of the 2016 Chemical Data Reporting (CDR) dataset and the initial interim list of active substances released with the June 2017 copy of the Toxic Substances Control Act (TSCA) Inventory (Inventory), the magnitude of effort that will be needed to comply with the Section 8(b)(4) inventory notification process is becoming clear. Even with EPA’s decision to designate as “active” substances that were subject to Notices of Commencement during the look-back period, manufacturers, importers, and processors must carefully review records to determine which of the over 72,000 substances not included on the current interim active list were manufactured, imported, or processed in the 10-year look-back period and waste no time in preparing to meet their obligations.

New TSCA requires that EPA review and make determinations on all new chemicals notifications submitted to EPA. These changes, which were effective as of the June 2016 enactment of the amended law, presented implementation challenges for EPA with the result that a backlog of unresolved premanufacture notification (PMN) cases accumulated as discussed in the June 12, 2017 Bloomberg BNA webinar“Reviewing New Chemicals under Amended TSCA:  Impact on Innovation”. EPA committed to and has largely eliminated this backlog. The panel will provide an update on EPA’s progress in addressing the backlog and discuss other emerging new chemical issues.

The webinar will be presented by a panel of former EPA officials and seasoned regulatory professionals discussing how to prepare for the forthcoming inventory notification deadlines and an update on EPA’s new chemical review process.

The webinar will consist of 75 minutes of presentation followed by a 15-minute Q&A.

Educational Objectives:
This 90-minute webinar will cover:
• Section 5 Inventory Reporting requirements and strategies 
• How to recognize and avoid when reporting
• Current state of play of EPA’s new chemicals review process 
• What you can do now to ensure your chemicals and chemical products get to market and stay there

Who would benefit most from attending this program?
Legal and regulatory practitioners engaged in chemical management law and policy; corporate Washington affairs teams; in-house legal and regulatory staff; scientists involved with “regulatory science”; and anyone wishing to understand the status of TSCA reform legislation and the state of domestic chemical management policy may find value in this webinar.

By registering for this event, I consent to having Bloomberg BNA, on behalf of itself and selected partners, contact me about offers and promotions, I also confirm that I have read and agreed to BNA’s privacy policy.

Already Registered?

To access the webinar, please use the following instructions:
1. A few minutes before the start time of the webinar, please go to https://learning.bna.com.
2. You will be asked to login.  Please enter your username and password (the one you used to register for the webinar) and click “GO”.
3. You will then be taken to your personalized classroom.  On the left hand side you will see a grey tool bar.  Please click on “my classroom”.
4. There, you will be able to click “play” for the webinar(s) that you have purchased. 
5. The webinar will not be accessible until the date and time of the webinar.


Lynn L. Bergeson, Managing Partner, Bergeson & Campbell, P.C.

Managing Partner of Bergeson & Campbell, P.C. (B&C®), Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the European Union’s Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation, and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether advocating before Congress, EPA, the U.S. Food and Drug Administration (FDA), or other governance and standard-setting bodies.

Charles M. Auer, Senior Regulatory and Policy Advisor, Bergeson & Campbell, P.C.

Charles M. Auer is Senior Regulatory and Policy Advisor with B&C. Mr. Auer’s experience includes over 32 years at the U.S. Environmental Protection Agency (EPA), most recently as the Director of the Office of Pollution Prevention and Toxics (OPPT), responsible for implementation of TSCA. Few people have delved so deeply into the workability, implementation, and strategic issues facing “new” TSCA as a result of the sweeping changes made to TSCA under the Frank R. Lautenberg Chemical Safety for the 21st Century Act as Mr. Auer.  

Richard E. Engler, Ph.D., Senior Chemist, Bergeson & Campbell, P.C.

Richard E. Engler, Ph.D., Senior Chemist with B&C, is a 17-year veteran of EPA and is one of the most widely recognized experts in the field of green chemistry, having served as senior staff scientist in OPPT and leader of EPA's Green Chemistry Program.  He has participated in thousands of TSCA substance reviews at EPA, as well as pre-notice and post-review meetings with submitters to resolve complex or difficult cases, and he draws upon this invaluable experience to assist B&C clients as they develop and commercialize novel chemistries.

Jeffery Morris, Ph.D., Director of the Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency

Jeffery Morris, Ph.D. is Director of EPA’s OPPT, which regulates chemicals under TSCA as well as administers the Pollution Prevention Act.  Dr. Morris has been with the EPA since 1992.  Prior to his current position, Dr. Morris was OPPT’s deputy director.  Before coming to OPPT, he served as the National Program Director for Nanotechnology, responsible for managing EPA’s Nanomaterials Research Program in EPA’s Office of Research and Development (ORD).  Dr. Morris has also served as the Acting Director in the ORD Office of Science Policy.

Lawrence E. Culleen, Partner, Arnold & Porter Kaye Scholer

Lawrence E. Culleen is Partner at Arnold & Porter Kaye Scholer. He represents clients on administrative, regulatory, and enforcement matters involving federal agencies such EPA, the U.S. Department of Agriculture (USDA), FDA, and the Consumer Product Safety Commission (CPSC). Prior to joining the firm, Mr. Culleen held significant positions at EPA serving as a manager in various risk-management programs which oversee pesticides, chemical substances, and biotechnology products, including Chief of Staff to the Assistant Administrator; Acting Director, Registration Division in the Office of Pesticide Programs; Chief, New Chemicals Branch; and Director, Asbestos In-Schools Loan and Grant Program.

Pat Rizzuto, Reporter, Bloomberg BNA

Pat Rizzuto covers chemical policies and the science that underpins them.